Skip to main content

Coronavirus Infections

Longitudinal Trajectories of Depression and Anxiety Among Chinese Adolescents in the Later Stage of the COVID-19 Pandemic.

Li H. Early Intervention in Psychiatry 2025;19(10):e70090.

Published on 20/10/2025
Effectiveness of SARS-CoV-2 testing strategies inreducing COVID-19 cases, hospitalisations, and deaths.

Saif-Ur-Rahman KM. Cochrane Database of Systematic Reviews 2025;10:CD016192.

Published on 6/10/2025
Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection.

Marking U. eBioMedicine 2025;:https://doi.org/10.1016/j.ebiom.2025.105912.

Published on 24/9/2025
Temporal trends in hospital-recorded pulmonary embolism in England before, during and after the COVID-19 pandemic (2008–2024): a population-based observational study.

Zhong X. The Lancet Regional Health – Europe 2025;:https://doi.org/10.1016/j.lanepe.2025.101433.

Published on 24/9/2025
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. The Lancet Infectious Diseases 2025;:https://doi.org/10.1016/S1473-3099(25)00361-5.

Published on 24/9/2025
Laboratory evaluation of 185 commercial assays for detecting SARS-CoV-2: the UK response for mass testing.

Bown A. eClinicalMedicine 2025;:https://doi.org/10.1016/j.eclinm.2025.103416.

Published on 24/9/2025
Evaluation of SARS-CoV-2 lateral flow device sensitivity: a comparison of systematic laboratory assessments with manufacturer-reported sensitivity.

Kulasegaran-Shylini R. eClinicalMedicine 2025;:https://doi.org/10.1016/j.eclinm.2025.103454.

Published on 24/9/2025
Leveraging the influenza sentinel surveillance platform for SARS-CoV-2 monitoring in Bangladesh (2020–2024): a prospective sentinel surveillance study.

Islam MA. The Lancet Regional Health - Southeast Asia 2025;:https://doi.org/10.1016/j.lansea.2025.100657.

Published on 24/9/2025
Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study.

Giles ML. eClinicalMedicine 2025;:https://doi.org/10.1016/j.eclinm.2025.103428.

Published on 24/9/2025
Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial.

Jantarabenjakul W. The Lancet Regional Health - Southeast Asia 2025;:https://doi.org/10.1016/j.lansea.2025.100650.

Published on 24/9/2025

...
12
13
14
15